T0	KEYPHRASE-NOTYPES 0 17	Efficacy analyses,"","wer"
T1	KEYPHRASE-NOTYPES 54 66	participants,"zed"," th"
T2	KEYPHRASE-NOTYPES 72 87	intent-to-treat,"the","(IT"
T3	KEYPHRASE-NOTYPES 89 92	ITT,"at "," sa"
T4	KEYPHRASE-NOTYPES 94 100	sample,"TT)"," Ly"
T5	KEYPHRASE-NOTYPES 102 114	Lyme patient,"le.","and"
T6	KEYPHRASE-NOTYPES 119 135	healthy controls,"and","wer"
T7	KEYPHRASE-NOTYPES 155 162	respect,"ith","to "
T8	KEYPHRASE-NOTYPES 182 215	baseline clinical characteristics,"and"," us"
T9	KEYPHRASE-NOTYPES 223 230	tests,"ing","for"
T10	KEYPHRASE-NOTYPES 235 254	continuous measures,"for","and"
T11	KEYPHRASE-NOTYPES 259 261	χ ^,"and"," te"
T12	KEYPHRASE-NOTYPES 263 268	tests,"χ^2","for"
T13	KEYPHRASE-NOTYPES 273 293	categorical measures,"for","\nT"
T14	KEYPHRASE-NOTYPES 295 301	nTests,"es.","and"
T15	KEYPHRASE-NOTYPES 306 315	estimates,"and","of "
T16	KEYPHRASE-NOTYPES 319 330	differences," of","bet"
T17	KEYPHRASE-NOTYPES 339 345	groups,"een","(IV"
T18	KEYPHRASE-NOTYPES 365 372	placebo," IV"," an"
T19	KEYPHRASE-NOTYPES 378 394	healthy controls,"and"," wi"
T20	KEYPHRASE-NOTYPES 401 408	respect,"ith","to "
T21	KEYPHRASE-NOTYPES 416 436	multivariate measure,"the","of "
T22	KEYPHRASE-NOTYPES 440 449	cognition," of","(si"
T23	KEYPHRASE-NOTYPES 455 462	domains,"six"," mo"
T24	KEYPHRASE-NOTYPES 464 469	motor,"ns:"," ps"
T25	KEYPHRASE-NOTYPES 471 482	psychomotor,"or,"," wo"
T26	KEYPHRASE-NOTYPES 492 498	memory,"ing"," at"
T27	KEYPHRASE-NOTYPES 500 509	attention,"ry,"," ve"
T28	KEYPHRASE-NOTYPES 511 525	verbal fluency,"on,"," an"
T29	KEYPHRASE-NOTYPES 532 538	memory,"nd "," ov"
T30	KEYPHRASE-NOTYPES 545 549	time,"ver","(ba"
T31	KEYPHRASE-NOTYPES 551 559	baseline,"me "," we"
T32	KEYPHRASE-NOTYPES 561 565	week,"ne,","12,"
T33	KEYPHRASE-NOTYPES 574 578	week,"and","24)"
T34	KEYPHRASE-NOTYPES 597 630	longitudinal mixed-effects models," on","(LM"
T35	KEYPHRASE-NOTYPES 632 635	LMM,"ls ",", ["
T36	KEYPHRASE-NOTYPES 665 676	correlation,"the","bet"
T37	KEYPHRASE-NOTYPES 689 696	domains,"the","and"
T38	KEYPHRASE-NOTYPES 713 736	peated observations,"the","ove"
T39	KEYPHRASE-NOTYPES 742 746	time,"ver"," [2"
T40	KEYPHRASE-NOTYPES 757 760	LMM,"The","inc"
T41	KEYPHRASE-NOTYPES 770 782	main effects,"ded","and"
T42	KEYPHRASE-NOTYPES 791 808	interaction terms,"all"," Ti"
T43	KEYPHRASE-NOTYPES 810 814	Time,"ms.","was"
T44	KEYPHRASE-NOTYPES 832 846	nominal factor,"s a","rat"
T45	KEYPHRASE-NOTYPES 861 880	continuous variable,"n a","\nI"
T46	KEYPHRASE-NOTYPES 906 928	three-way interactions,"and"," th"
T47	KEYPHRASE-NOTYPES 934 939	model,"the","for"
T48	KEYPHRASE-NOTYPES 948 968	covariance structure,"the","was"
T49	KEYPHRASE-NOTYPES 1002 1031	Bayesian information criteria,"ing"," [2"
T50	KEYPHRASE-NOTYPES 1053 1058	model,"the","for"
T51	KEYPHRASE-NOTYPES 1067 1077	covariance,"the","as "
T52	KEYPHRASE-NOTYPES 1109 1120	elimination,"ard","was"
T53	KEYPHRASE-NOTYPES 1151 1156	model,"st”","for"
T54	KEYPHRASE-NOTYPES 1165 1179	mean structure,"the"," In"
T55	KEYPHRASE-NOTYPES 1181 1190	Inference,"re.","reg"
T56	KEYPHRASE-NOTYPES 1205 1215	comparison,"the","bet"
T57	KEYPHRASE-NOTYPES 1228 1234	groups,"the","was"
T58	KEYPHRASE-NOTYPES 1257 1262	model,"est"," Si"
T59	KEYPHRASE-NOTYPES 1264 1289	Significant omnibus tests,"el.","for"
T60	KEYPHRASE-NOTYPES 1294 1309	ITT differences,"for","amo"
T61	KEYPHRASE-NOTYPES 1326 1332	groups,"ree","ove"
T62	KEYPHRASE-NOTYPES 1338 1342	time,"ver","(tw"
T63	KEYPHRASE-NOTYPES 1344 1355	two-sided α,"me ","0.0"
T64	KEYPHRASE-NOTYPES 1379 1399	pairwise comparisons," by"," th"
T65	KEYPHRASE-NOTYPES 1405 1413	p values,"the","for"
T66	KEYPHRASE-NOTYPES 1424 1428	post,"ese","hoc"
T67	KEYPHRASE-NOTYPES 1433 1438	tests,"hoc","are"
